Dr. Doris Quon, MD

Claim this profile

Orthopaedic Institute for Children

Studies Hemophilia
Studies Hemophilia B
4 reported clinical trials
4 drugs studied

Affiliated Hospitals

Image of trial facility.

Orthopaedic Institute For Children

Image of trial facility.

Orthopaedic Institute For Children Hemophilia Program

Clinical Trials Doris Quon, MD is currently running

Image of trial facility.

Natural History Study

for Blood Disorders

In parallel with the growth of ATHN's clinical studies, the number of new therapies for all blood disorders is increasing significantly. Some of the recently FDA-approved therapies for congenital and acquired hematologic conditions have not yet demonstrated long-term safety and effectiveness beyond the pivotal trials that led to their approval. In addition, results from well controlled, pivotal studies often cannot be replicated once a therapy has been approved for general use.2,3,4,5 In 2019 alone, the FDA has issued approvals for 24 new therapies for congenital and acquired hematologic conditions.6 In addition, almost 10,000 new studies for hematologic diseases are currently registered on www.clinicaltrials.gov.7 With this increase in potential new therapies possible, it is imperative that clinicians and clinical researchers in the field of non-neoplastic hematology have a uniform, secure, unbiased, and enduring method to collect long-term safety and efficacy data. As emphasized in a recently published review, accurate, uniform and quality national data collection is critical in clinical research, particularly for longitudinal cohort studies covering a lifetime of biologic risk.8

Recruiting

1 award

N/A

1 criteria

Image of trial facility.

SEVENFACT®

for Hemophilia

Phase IV multi-center, US-centric, open-label, safety study enrolling participants with Hemophilia A or B with inhibitors, 12 years of age and older, who are either on long term prophylactic treatment (e.g., emicizumab) at risk of experiencing a breakthrough bleeding event (BE), or who are not on prophylactic treatment who may need to control a BE.

Recruiting

3 awards

Phase 4

6 criteria

More about Doris Quon, MD

Clinical Trial Related

5 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical Trials

Treatments Doris Quon, MD has experience with

  • Liver Transplantation
  • Coagulation Factor VIIa [recombinant]-jncw
  • ATHN Transcends
  • SPK-8016

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Doris Quon, MD specialize in?

Is Doris Quon, MD currently recruiting for clinical trials?

Are there any treatments that Doris Quon, MD has studied deeply?

What is the best way to schedule an appointment with Doris Quon, MD?

What is the office address of Doris Quon, MD?

Is there any support for travel costs?